# Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors

> **NCT00590343** · PHASE2 · COMPLETED · sponsor: **Louisiana State University Health Sciences Center in New Orleans** · enrollment: 23 (actual)

## Conditions studied

- Metastatic Neuroendocrine Tumors

## Interventions

- **DRUG:** vatalanib

## Key facts

- **NCT ID:** NCT00590343
- **Lead sponsor:** Louisiana State University Health Sciences Center in New Orleans
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2011-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00590343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00590343, "Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00590343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*